Scientists from the University of Illinois Chicago and Harvard University have developed a new antibiotic, cresomycin, as a potential tool against drug-resistant bacteria. This achievement stems from research into how antibiotics interact with the bacterial ribosome and strategies to overcome bacterial defenses, like ribosome modification. Cresomycin’s effectiveness against multidrug-resistant strains in animal studies signals its promise for human applications, highlighting the crucial role of structural biology in advancing antibiotic development.
SciTechDaily
210 ngày
